These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9696959)

  • 1. Prescription changes and drug costs at the interface between primary and specialist care.
    Bijl D; Van Sonderen E; Haaijer-Ruskamp FM
    Eur J Clin Pharmacol; 1998 Jun; 54(4):333-6. PubMed ID: 9696959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is new drug prescribing in primary care specialist induced?
    Florentinus SR; Heerdink ER; van Dijk L; Griens AM; Groenewegen PP; Leufkens HG
    BMC Health Serv Res; 2009 Jan; 9():6. PubMed ID: 19134223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescriptions of low therapeutic value imposed on primary care].
    Seguí Díaz M; Bartolozzi Castilla E; Ramos Aleixades J; Llach Fernández A; Torrent Quetglas M; Besco Villegas E; Pérez Martos M
    Aten Primaria; 1998 Sep; 22(4):227-32. PubMed ID: 9803575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of topical immunomodulator therapy in Medicare patients varies by prescriber specialty.
    Zhang M; Silverberg JI; Kaffenberger BH
    J Am Acad Dermatol; 2017 May; 76(5):925-931. PubMed ID: 28162853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential savings from generic prescribing and generic substitution in South Africa.
    Karim SS; Pillai G; Ziqubu-Page TT; Cassimjee MH; Morar MS
    Health Policy Plan; 1996 Jun; 11(2):198-205. PubMed ID: 10158460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Induced drug prescription in oncology patients].
    Mas Arcas C; Pascual Plá F; Escrivá Muñz JJ; Boscas Mayans R
    Farm Hosp; 2004; 28(2):97-100. PubMed ID: 15101800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of substituting general practitioners with nurse practitioners on resource use, production and health-care costs during out-of-hours: a quasi-experimental study.
    Van Der Biezen M; Adang E; Van Der Burgt R; Wensing M; Laurant M
    BMC Fam Pract; 2016 Sep; 17(1):132. PubMed ID: 27619968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substitution of hospital care with Primary Care Plus: differences in referral patterns according to specialty, specialist and diagnosis group.
    Smeele P; Kroese MEAL; Spreeuwenberg MD; Ruwaard D
    BMC Fam Pract; 2019 Jun; 20(1):81. PubMed ID: 31185921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
    Counterweight Project Team
    J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of outpatient care with primary care: a feasibility study on the experiences among general practitioners, medical specialists and patients.
    van Hoof SJ; Spreeuwenberg MD; Kroese ME; Steevens J; Meerlo RJ; Hanraets MM; Ruwaard D
    BMC Fam Pract; 2016 Aug; 17():108. PubMed ID: 27506455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Differences between prescription and dispensing of generic medicines in primary care. When the exception is the rule].
    Díez JI; Benounna H; Mayol CV; García RM
    Gac Sanit; 2007; 21(5):404-6. PubMed ID: 17916305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost of medicines in the United Kingdom. A survey of general practitioners' opinions and knowledge.
    Silcock J; Ryan M; Bond CM; Taylor RJ
    Pharmacoeconomics; 1997 Jan; 11(1):56-63. PubMed ID: 10165527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug costs in reformed primary care: effect of training activities on drug savings].
    Mengíber Torres FJ
    Gac Sanit; 2000; 14(4):277-86. PubMed ID: 11094844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.
    Haas JS; Phillips KA; Gerstenberger EP; Seger AC
    Ann Intern Med; 2005 Jun; 142(11):891-7. PubMed ID: 15941695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of different kinds of user fee on prescribing costs in rural Nepal.
    Holloway KA; Gautam BR; Reeves BC
    Health Policy Plan; 2001 Dec; 16(4):421-7. PubMed ID: 11739367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to improve outpatient referrals from primary care to secondary care.
    Akbari A; Mayhew A; Al-Alawi MA; Grimshaw J; Winkens R; Glidewell E; Pritchard C; Thomas R; Fraser C
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD005471. PubMed ID: 18843691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brand Medications and Medicare Part D: How Eye Care Providers' Prescribing Patterns Influence Costs.
    Newman-Casey PA; Woodward MA; Niziol LM; Lee PP; De Lott LB
    Ophthalmology; 2018 Mar; 125(3):332-339. PubMed ID: 28625684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.
    Zhang M; Silverberg JI; Kaffenberger BH
    J Am Acad Dermatol; 2017 Sep; 77(3):448-455.e2. PubMed ID: 28651825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.
    Ballesteros LC; Fernández San Martín MI; Sanz Cuesta T; Escortell Mayor E; López Bilbao C
    Pharmacoeconomics; 2001; 19(5 Pt 1):513-22. PubMed ID: 11465310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.